Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
CALL
RTX Corp
RTX
$298B
| $152M | 0.04% |
1,585,400
+499,800
| +46% | +$48M |
|
377
PUT
KLA
KLAC
$272B
| $152M | 0.04% |
4,773,000
+3,017,000
| +172% | +$101M |
|
378
CALL
Uber
UBER
$154B
| $152M | 0.04% |
7,438,800
-2,062,000
| -22% | -$54.7M |
|
379
PUT
United Airlines
UAL
$40.7B
| $152M | 0.04% |
4,287,900
-1,246,400
| -23% | -$54.7M |
|
380
PUT
T-Mobile US
TMUS
$190B
| $151M | 0.04% |
1,124,300
+265,900
| +31% | +$34.7M |
|
381
Vistra
VST
$49.2B
| $151M | 0.04% |
6,603,073
+359,148
| +6% | +$8.88M |
|
382
CrowdStrike
CRWD
$225B
| $151M | 0.04% |
3,579,244
+2,383,312
| +199% | +$108M |
|
383
PUT
Marvell Technology
MRVL
$199B
| $151M | 0.04% |
3,457,800
+973,900
| +39% | +$55.2M |
|
384
CALL
ARK Innovation ETF
ARKK
$6.41B
| $150M | 0.04% |
3,761,200
-1,198,200
| -24% | -$57M |
|
|
TWTR
385
DELISTED
Twitter, Inc.
TWTR
| $150M | 0.04% |
3,999,633
+3,303,113
| +474% | +$142M |
|
386
Thermo Fisher Scientific
TMO
$223B
| $148M | 0.04% |
272,684
+241,031
| +761% | +$133M |
|
387
PUT
Applied Materials
AMAT
$438B
| $148M | 0.04% |
1,627,800
+123,100
| +8% | +$13.5M |
|
388
CALL
Take-Two Interactive
TTWO
$45.5B
| $148M | 0.04% |
1,207,864
+355,664
| +42% | +$45.3M |
|
389
PUT
Wynn Resorts
WYNN
$10.8B
| $148M | 0.04% |
2,596,600
+560,100
| +28% | +$37M |
|
390
Apollo Global Management
APO
$81B
| $147M | 0.04% |
3,039,494
+2,600,257
| +592% | +$141M |
|
391
CALL
Altria Group
MO
$108B
| $147M | 0.04% |
3,527,600
-472,400
| -12% | -$24.5M |
|
|
392
Marvell Technology
MRVL
$199B
| $147M | 0.04% |
3,375,500
+1,149,476
| +52% | +$65.2M |
|
393
CALL
Danaher
DHR
$145B
| $146M | 0.04% |
649,841
+179,578
| +38% | +$41.4M |
|
394
PUT
American Airlines Group
AAL
$9.97B
| $146M | 0.04% |
11,498,000
+59,700
| +0.5% | +$994K |
|
395
CALL
Estee Lauder
EL
$32B
| $145M | 0.04% |
569,300
+119,500
| +27% | +$30.3M |
|
|
DFS
396
DELISTED
Discover Financial Services
DFS
| $143M | 0.04% |
1,511,631
+610,897
| +68% | +$65.4M |
|
397
CALL
Abbott
ABT
$192B
| $143M | 0.04% |
1,315,300
-14,500
| -1% | -$1.65M |
|
398
L3Harris
LHX
$52.8B
| $143M | 0.04% |
590,570
+392,101
| +198% | +$94.6M |
|
399
PUT
Snap
SNAP
$8.93B
| $143M | 0.04% |
10,858,000
-1,420,500
| -12% | -$32.4M |
|
400
CALL
Zoetis
ZTS
$29.9B
| $142M | 0.04% |
828,300
+78,200
| +10% | +$13.5M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.